P4D-15718-11851
3 vaccinations
3 coded responses
34 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 571 / SD
- Registered
- 2022-07-12
- Relationship
- Child or adolescent in my care
- Guardian
- T4K-26823-73226
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-12
Registered in v-safe
-
2022-07-13
Dose 1 — Pfizer-BioNTech
-
2022-07-14
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
-
2022-07-15
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
-
2022-07-16
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-27
- 2022-08-05
-
2022-08-08
Dose 2 — Pfizer-BioNTech
- 2022-08-08
-
2022-08-09
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-08-10
- 2022-08-11
- 2022-08-12
- 2022-08-13
- 2022-08-14
- 2022-08-15
-
2022-08-22
Survey response — day 14, dose 2, under 3MedDRA: Nasal congestion, Nasopharyngitis — Feeling: FairFree text: Nasal congestion from a coldMedDRA releases: 2024-11 · check-in free text available
- 2022-08-29
- 2022-09-05
- 2022-09-12
- 2022-09-19
-
2022-10-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-06
- 2022-10-07
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-18
- 2022-10-25
-
2022-11-01
Survey response — day 28, dose 3, under 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Cold symptoms: runny nose, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-11-08
- 2022-11-15
-
2023-01-03
Survey response — 3 months, dose 3, under 3MedDRA: Cough, Decreased appetite, Exposure to SARS-CoV-2, Fatigue, Irritability, Malaise, Nasal congestion, Pyrexia, Suspected COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-13 | Pfizer-BioNTech | No |
| 2 | 2022-08-08 | Pfizer-BioNTech | No |
| 3 | 2022-10-04 | Pfizer-BioNTech | Flu |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Nasal congestion from a cold
Release 12 (Under 3) — day 28, dose 3, under 3
Symptoms: Cold symptoms: runny nose, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Suspected COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release